C-19 Injections: Massive Regulatory and Manufacturing Fraud
Ex-pharmaceutical industry and biotech executive Alexandra Latypova shares hers findings.
By: Tessa Lena
STORY AT-A-GLANCE
Alexandra Latypova is an ex-pharmaceutical industry and biotech executive with a lot of experience in the areas of drug safety and clinical trials
Early on, she discovered that, based on the number of reported deaths and adverse events per lot, there was unprecedented variability in the toxicity of the product
According to A…
Keep reading with a 7-day free trial
Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.